Structure-based screening techniques for drug discovery

Details Structure-based screening techniques for drug discovery Structure-based screening techniques for drug discovery

2005-03-08

2005-03-08

LeGuyader, John L. (Department: 1635)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S350000

Reexamination Certificate

active

06864359

ABSTRACT:
The invention relates to novel non-naturally occurring cell surface receptor analogs, ligand analogs and nucleic acids encoding them. The invention further provides methods for screening of ligand analogs and bioactive agents capable of modulating the signaling activity of a non-naturally occurring cell surface receptor analog or capable of binding to a non-naturally occurring cell surface receptor analog.

REFERENCES:
patent: 5292654 (1994-03-01), Yoshimura et al.
patent: 5844099 (1998-12-01), Stahl et al.
patent: 5889143 (1999-03-01), Ochoa et al.
patent: 5968752 (1999-10-01), Ichijo et al.
patent: 6093547 (2000-07-01), Jin et al.
patent: 0 603 8787 (1994-02-01), None
patent: 0 742 438 (1996-11-01), None
patent: 9429458 (1994-12-01), None
patent: 9847089 (1998-10-01), None
Dahiyat et al., “Protein design automation,”Protein Science,5:895-903 (1996).
Jolliffe et al., “Erythropoietin Receptor: Application in Drug Development,” Nephrol. Cial. Transplant., 10(suppl. 2): 28-34 (1995).
Quelle et al., “Mutations in the WSAWSE and Cytosolic Domains of the Erythropoietin Receptor Affect Signal Transduction and Ligand Binding and Internalization,” Molecular and Cellular Biology, 12(10): 4553-4561 (1992).
Barbone et al., “Mutagenesis Studies of the Human Erthropoietin Receptor,” The Journal of Biological Chemistry, 272(8): 4985-4992 (1997).
Johnson et al., “Refolding, Purification, and Characterization of Human Erythropoietin Binding Protein Produced inEscherichia coli,” Protein Expression and Purification, 7:104-113 (1996).
Livnah et al., “An Antagoisnt Peptide-EPO Receptor Complex Suggests that Receptor Dimerization is not Sufficient for Actviation,” Nature Structural Biology, 5(11): 993-1003 (1998).
McConnell et al., Isolation of Erythropoietin Recetpor Agonist Peptides Using Evolved Phage Libraries, Biol. Chem., 379:1279-1286 (1998).
Wrighton et al., “Small Peptides as potent Mimetics of the Protein Hormone Erythropoietin,” Science, 273:458-463 (1996).
Edgington, S. “Superfamily Structure And Biotech Drug Development,” Biotechnology, 10:1529-1534 (1992).
Middleton et al., “Critical Erythropoietin (EPO) Binding Determinanats on the EPO Receptor also Interact,” Blood, 88(10): 661A, abstract (1996).
Borman, “Proteins to Order,” Chemical and Engineering Newsletter (C&EN) Oct. 6, 1997, 9-10 (1997).
Lazar et al., “De novo design of the hydrophobic core of ubiquitin,” Protein Science 6:1167-1178 (1997).
Desjarlais et al., “New strategies in protein design,” Current Opinion in Biotechnology 6:460-466 (1995).
Wodak, S.J., et al., “Analytical approximation to the accessible surface area of proteins”,Proc. Natl. Acad. Sci. USAvol. 77(4):1736-1740 (Apr. 1980).
Muñoz, V., et al., “Analysis of the effect of local interactions on protein stability”,Folding&Design1(3):167-178 (Apr. 1996).
Dunbrack Jr., R.L., et al., “Conformational analysis of the backbone-dependent rotamer preferences of protein sidechains”,Struc. Biol.vol. 1(5):334-340 (May 1994).
Hellinga, H.W., et al., “Construction of New Ligand Binding Site in Proteins of Known Structure”,J. Mol. Biol.222:763-785 (1991).
Desmet, J., et al., “The Dead End Elimination' Theorem as a New Approach to the Side Chain Packing Protein”, from “The Protein Folding Problem and Tertiary Structure Prediction” Ch. 10:1-49 (1994).
Lasters, I., et al., “Dead-End Based Modeling Tools to Explore the Sequence Space That is Compatible with a Given Scaffold”,Jour. of Protein Chem.vol. 16(5):449-452 (Jul. 1997).
Sun, S., et al., “Designing amino acid sequences to fold with good hydrophobic cores”,Protein Engg.vol. 8(12):1205-1213 (1995).
Desmet, J. et al., “The dead-end elimination theorem and its use in protein side-chain positioning”,Naturevol. 356:539-542 (Apr. 1992).
Bowie, J.U., et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”,Sciencevol. 247:1306-1310 (Mar. 1990).
Desjarlais, J.R., et al., “De novo design of the hydrophobic cores of proteins”,Protein Science4:2006-2018 (1995).
Pabo, C., “Designing proteins and peptides”,Naturevol. 1:200 (Jan. 1983).
Jones, D.T., “De novo protein design using pairwise potentials and a genetic algorithm”,Protein Science3:567-574 (1994).
Goldstein, R.F., “Efficient Rotamer Elimination Applied to Protein Side-Chains and Related Spin Glasses”,Biophys. Jour.vol. 66:1335-1340 (May 1994).
Mayo et al., “First fully automatic design of a protein achieved by Caltech scientists”, new press release (Oct. 1997).
Smith, C.K., et al., “Guidelines for Protein Design: The Energetics of β Sheet Side Chain Interactions”,Sciencevol. 270:980-982 (Nov. 1995).
Regan, L., “Helix is a helix is a helix?”,Proc. Natl. Acad. Sci. USAvol. 94:2796-2797 (Apr. 1997).
Muñoz, V., et al., “Intrinsic Secondary Structure Propensities of the Amino Acids, Using Statistical φ-ψ Matrices: Comparison with Experimental Scales”,Proteins20:301-311 (1994).
Stickle et al., “Bydrogen Bonding in Globular Proteins,” Journal of Molecular Biology, 226:1143-1159 (1992).
Lasters et al., “Enhanced dead-end elimination in the search for the global minimum energy conformation of a collection of protein chains,” Protein Engineering, 8(8):815-822 (1995).
Desmet et al., “Theoretical and Algorithmical Optimization of the Dead-End Elimination Theorem,”Proceedings of the Pacific Symposium on Biocomputing '97, 122-133 (1997).
Holmes, “First-ever designer protein fits like a glove,” New Scientist, IPC Magazines Limited, Oct. 11, 1997 (1997).
Muñoz, V., et al., “Helix design, prediction and stability”,Curr. Opin. in Biotech.6:382-386 (Aug. 1995).
Minor Jr., D.L., “Measurement of the β-sheet-forming propensities of amino acids”,Naturevol. 367:660-663 (Feb. 1994).
Hellinga, H.W., et al., “Optimal sequence selection in proteins of known structure by simulated evolution”,Proc. Natl. Acad. Sci., USAvol. 91:5803-5807 (Jun. 1994).
Bowie, J.U., et al., “A Method to Identify Protein Sequences that Fold into a Known Three-Dimensional Structure”,Sciencevol. 253:164-170 (Jul. 1991).
Dalal, S., et al., “Protein alchemy: Changing β-sheet into α-helix”,Nature Struc. Biol.vol. 4(7):548-552 (Jul. 1997).
Dahiyat, B.I., et al., “Proteins from Scratch”, press digest email byScience(Sep. 26, 1997).
Berry, A., et al., “A quantitative methodology for the de novo design of proteins”,Protein Sci.3:1871-1882 (Oct. 1994).
Hellinga, H.W., “Rational protein design: Combining theory and experiment”,Proc. Natl. Acad. Sci, USAvol. 94:10015-10017 (Sep. 1997).
Padmanabhan, S., et al., “Relative helix-forming tendencies of nonpolar amino acids”,Naturevol. 344:268-270 (mar. 1990).
Connolly, M.L., “Solvent-Accessible Surfaces of Proteins and Nucleic Acids”,Sciencevol. 221(4612):709-713 (Aug. 1983).
Eisenberg, D., et al., “Solvation energy in protein folding and binding”,Naturevol. 319:199-203 (Jan. 1986).
Ponder, J.W., et al., “Use of Packing Criteria in the Enumeration of Allowed Sequences for Different Structural Classes”, release byAcad. Press Inc.(Londonl)Ltd.pp.775-791 (1987).
Dahiyat, B.I., et al., “Automated design of the surface positions of protein helices”,Protein Science6:1-5 (Jun. 1997).
Harbury et al., “High-Resolution Protein Design with Backbone Freedom,”Science,282:1462-1467 (1998).
Kortemme et al., “Design of a 20-Amino Acid, Three-Stranded β-Sheet Protein,”Science,281:253-256 (1998).
Koehl et al., “De Novo Protein Design

Affiliated with

Also associated with

Rating

Structure-based screening techniques for drug discovery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Structure-based screening techniques for drug discovery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Structure-based screening techniques for drug discovery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3396784